| Term 
 | Definition 
 
        | 
hypertension, sedative, opioid withdrawalcentrally acting sympatholyticα-2 agonist = ↓ cAMP = inhibitorycan also ↓ aqueous humor in the eye to ↓ intraocular pressurecauses ↓ ACh release ➞ ↓ M3 activation in GI ➞ ↓ GI motility (constipation or treat diarrhea α2 agonist in respiratory ➞ ↓ respiration↓ NE in CNS = ↓ SNS and ↑ PSNS = ↓ CO + PVR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertension, heart failure + excessive tachycardia, angina, arrhythmia non-selective β-blocker↓ HR and COb/c ↓ HR ➞ vasoconstriction of organ and skinused frequentlyalso causes: ↓ secretion in eye, contraction of smooth muscle, and vasoconstriction in skeletal muscletoxicities are with β2 blockade (asthma) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 hypertension, heart failure + excessive tachycardia, angina, arrhythmiaselective β1-blockerblock β1 in heart = ↓ COb/c ↓ HR body compensates ➞ vasoconstrictionblock β1 in juxta-glomerular of kidney = ↓ renin release = ↓ PVRalso causes: ↓ secretion in eye |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertensionselective α1-blockerblock α1 in arterioles and venules = relax blood vesselsbody compensates with ↑ HR and ↑ renin = may need diuretics or β-blockers tooalso causes: relaxation of dilator muscle, ↑ secretion in eye, relaxation of sphincters, relaxation of pilomotor musclestoxicity = rare and mild (dizziness and headache) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertensionnitric oxide donorused in emergencies (short-acting)toxicities = hypotension and cyanide accumulation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertension, angina, arrhythmiacalcium channel blocker inhibits calcium influx into atrial smooth muscle cells ➞ relaxation ➞ vasodilationtoxicity = bradycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 hypertension, mild heart failure, left ventricular dysfunction (no edema)ACE inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertension, mild heart failure, left ventricular dysfunction (no edema)AT1 receptor blockereffectiveness similar to ACE inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertension, mild heart failure, heart failure + edmathiazide diureticinhibit NaCl transport in distal convoluted tubule = ↑ NaCl in urine = ↑ H2O in urine = ↓ blood volume = ↓ BPtoxicities: hypokalemia, gout, dehydration |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
hypertensionloop diureticinhibits cotransport of Na+, K+, and Cl- = inhibit NaCl reabsorption inhibited severe hypertensino and pulmonary edematoxicities: same as hydrochlorotriazide, and does-dependent ototoxicity (hearing loss) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
congestive heart failure + atrial fibrillation or enlarged/dysfunctional left ventricle cardiac glycoside inhibits Na+/K+ ATPasedirect effect: ↑ Na+ inside cell ➞ ↓ Ca2+ efflux out of cell ➞ ↑ intracellular Ca2+ ➞ ↑ interaction between actin + myosin ➞ ↑ cardiac contractility (strengthen output)indirect effect: ↑ PSNS and ↓ SNS activity from improved circulation ➞ ↓ baroreceptor activation (↓ rate and how hard heart has to work)therefore ↑ force and ↓ rate of contraction toxicities: arrhythmia (people with low K+) ➞ tachycardia and fibrillation, Quinidine reduces clearance, GI toxicities (anorexia, nausea, vomiting, and diarrhea)  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
anginanitrate goup converted to NO ➞ ↑cGMP ➞ relaxation of smooth muscle ➞ vasodilation (and other tissues ie. bronchioles)effects = ↓ venous return, ↓ PVR, dilation of coronary arteries ➞ ↓ O2 requirements and ↑ O2 deliverytoxicities: hypotension, tachycardia (baroreceptore reflex), headaches, and when used with sildenafil |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
arrhythmia (all types)Na+ channel blockerprolongs Na+ channel in inactive phase ➞ subsequent stimulation of Na+ is delayedlong-term treatment |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
arrhythmia ventricular tachycardia/fibrillationemergency situationssame mechanism as Quinidine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
arrhythmiasK+ channel blockerprolongs action potential duration ➞ delays time for next APalso effects β-receptors + Na+/Ca+ channelsmost common for atrial fibrillations, ventricular tachycardia) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
mild-moderate Alzheimer’s Acetylcholine esterase inhibitor inhibit breakdown of AChside effects = similar to peripheral acting AChE inhibitors (primarily autonomic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
precursor to dopamine, norepinephrine, epinephrinecan ↑ dopamine levels in brain converted to dopamine by L-amino acid dexarboxylase (DDC)side effects = hypotension, arrhythmias, nausea, disturbed respiration, hair loss, confusion, extreme emotions (ie. anxiety), insomina, narcolepsy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Parkinsonsdopamine agonist (D2, D3, D4 receptors) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
Parkinsonsantimuscarinic   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
psychosisbutyrophenone derivative receptor antagonist: D2 > α1 > D4 > 5-HT2a > D1 > H1 side effects: parkinson-like symptoms (D2 blockade), hypotension (α1 blockade) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
psychosisatypical receptor antagonist: 5-HT2a > H1 > D4 > D2 > α1 > D1side effects: sedation (5-HT2a blockade) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
bipolar (most effective against mania)may ↑ serotonin and ↓ NE + dopamine neurotransmissionlithium ➞ ↓ in precursors for IP2 and DAG synthesis ➞ ↓ IP3 + DAG when receptors linked to second messengers are activated (ie. muscarinic, α1, 5-HT2a receptors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
depressiontricyclic antidepressant ↓ NE and serotonin re-uptakeadverse effects b/c = blocks cardiac sodium channels and is antagonist at muscarinic, histaminic, and α1 receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
depressionweak inhibitor of re-uptake and stimulates release of NE and dopaminedoesnt block histaminic, adrenergic, or muscarinic receptorsincreases dopamine levels (not good in psychosis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
depression, anxiety, OCD, bulemiamost widely prescribedserotonin re-uptake inhibitor side effect: insomnia, sexual dysfunction, ↑ suicide rates in children, inhibits CYP2D6 (overdose when taken with other antidepressants) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
depressionMAO inhibitornot selective for MAO-A or MAO-B therefore ↑ NE, serotinin, and dopamineonly used when tricyclic don’t work no significant side-effects when taken on their ownwhen taken with a tyarmine-containing food or with CNS stimulants ➞ hypertensive crisisdo not take with any seroternergic agents (SSRIs, SNRIs, tricyclics) ➞ serotonin syndrome sympatheticomimetics contradicted in people taking MAOIs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
anxiety, ethanol withdrawala benzodiazepineall metabolites are activeenhances GABA neurotransmission by binding to GABAa receptor at different site and ↑ binding frequency of GABA-mediated opening of Cl- channelenhance Cl- conductance ➞ ↑ inhibition of many neurons in many brain regions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
anxietya barbiturateenhances GABA neurotransmission by binding GABAa at different site and ↑ duration of opening of GABA-mediated Cl- channelsat high doses can directly activate GABAa and inhibit glutamate receptors and high-frequency sodium channels (lower therapeutic margin)also ↑expression of some cytochrome P450 enzymes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
a sedative-hypnotic↓ membrane excitability, ↑GABAa, ↓NMDA activation ➞ dose-dependent CNS depressionalso: ↓ myocardial contractility, ↓ anxiety, slurred speech, impaired judgment toxicicity: CNS and respiratory depressionchronic use: fatty liver ➞ hepatitis ➞ cirrhosis ➞ liver failure, pancreatitis, gastritis, malnutrition |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
metabolizes ➞ formaldehyde ➞ formic acidformic acid accumulation causes blindnesstreat with ethanol (compete for alcohol dehydrogenase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
drug of abuseopioidpresynaptic: binds to μ receptor linked to G-protein ➞ ↓ Ca+ ➞ ↓ release of neurotransmitters (GABA and glutamate)postynaptic: binds to μ receptor ➞ ↑ K+ efflux ➞ inhibits postsynaptic renurons (more negative and harder to activate)overdoes: respiratory depression ➞ coma ➞ deathmethadon and chlonidine to treat withdrawal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
drugs of abusestimulanthighly addictive↓ re-uptake of NE, dopamine, and serotonin ➞ ↑ alertness and euphoriaside-effects: psychosis, delusions, excess SNS activityoverdoes: intracranial hemorrhage, stroke, seizure, arrhythmia, heart attack, hyperthermia, coma, death |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
drug of abusestimulant↑ release of NE, dopamine, and serotonin ➞ ↑ alertness and euphoriaside-effects: psychosis, delusions, excess SNS activityoverdose: hyperthermia, serotonin syndrome, seizures, neuronal damage |  | 
        |  | 
        
        | Term 
 
        | LSD (lysergic acid diethylamide), mescaline, psilocybin |  | Definition 
 
        | 
drug of abuse5-HT2a partial agonist causes visual illusions and perceptual distortionside effects: panic, psychosis, strong uterine contractions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
drug of abuseNMDA receptor antagonistcauses visual illusions and perceptual distortionside effects: panic, psychosiscan be fatal in overdose    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
drug of abuse, cancer, glaucoma, AIDSTHC binds cannaboid receptor (CB1 and CB2) linked to G-protein ➞ inhibits GABA or glutamate releaseinitial effect: euphoria, laughter, altered sense of timesecondary effect: relaxation, introspection, ↓ reaction time, ↓ learning/memoryside effects: can causes paranoia, anxiety, hallucinationschronic: bronchitis, lung cancer  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
sedative and analgesicα-2 agonistsstimulate α2 receptor ➞ open K+ channels ➞ inhibit neurotransmitter release in braincauses: sedation, analgesia, hypotension, muscle relaxing, ↓ O2 exchange       |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
sedative-hypnotic, muscle relaxantbenzodiazepineenhances GABA neurotransmission by binding to GABAa receptor at different site and ↑ binding frequency of GAMA-mediated opening of Cl- channelenhance Cl- conductance ➞ ↑ inhibition of many neurons in many brain regionlittle effect on cadiovascular system and little respiratory depressant at therapeutic dosesside effect: drowsiness and confusion, CNS depression with alcohol useadverse effects reversed by flumazenil (GABAa antagonist) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
analgesic, sedative, cough suppressionopioidstimulate pre-synaptic μ-opioid receptor in CNS ➞ inhibits GABA and glutamate release ➞ intense analgesiaside effects: constipation, nausea, urine retension, dose-dependent resp depression (death in overdose) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
good analgesia but weaker effect at μ receptor (partial agonist)opioid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
reverse opioid overdose, opioid effects after surgery, or for shocky patients opioid receptor antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
1000-8000 X more potent than morphine opioidused in wild-lifereversal agent = M5050 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
induction agent and short term anesthesiabarbituate enhances GABA neurotransmission by binding GABAa at different site and ↑ duration of opening of GABA-mediated Cl- channelsat high doses can directly activate GABAa and inhibit glutamate receptors and high-frequency sodium channels (lower therapeutic margin)does-dependent CNS but partial does causes excitement, less smooth recovery (esp if multiple doses)effects: does-dependent resp depression, 30 second apnea,  hypotension, and extravascular damage |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
induction agent and short proceduresfacilitates effect of GABA at GABAa in brain ➞ inhibits action potentialssmooth induction without excitement stage, rapid smooth recoveryadverse effects: dose-dendent resp depression, 60 second apnea, hypotension, diarrhea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
dissociative anasthetic and moderate analgesicinhibits NMDA and GABA inhibits perception of signals associated with senses without totally abolishing consciousnessdissociative = open eyes, swallow, can hear, intense muscle rigidity, hallucinations, disconnected from surroundings and pain adverse effects: hypo- or hyperthermia, mood alterations, floating, vivid dreams, hallucinations, ↑ BP, minimal resp depression, can precipitate seizures, excitement if used alone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
inhaled anesthetichalogenate hydrocarbonfacilitates GABA at low concentrations and directly activates GABA receptors at high concentrations ➞ opens Cl- channels ➞ inhibits APsadverse effects: liver damage (25% metabolism), ↓ CO + EP release + ↑ sensitivity to EP ➞ arrhythmias, hypothermia, malignant hyperthermia (inherited disorder)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
inhaled anesthetichalogenate hydrocarbonfacilitates GABA at low concentrations and directly activates GABA receptors at high concentrations ➞ opens Cl- channels ➞ inhibits APsonly 0.2% metabolized and low solubility in tissues ➞ less hepatic damage, less depression of CO, less potenet than halothaneadverse effects: dose-dependent ↓ in BP and bad odour |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
inhaled anesthetichalogenate hydrocarbonfacilitates GABA at low concentrations and directly activates GABA receptors at high concentrations ➞ opens Cl- channels ➞ inhibits APsless odour and even less soluble in tissues than isoflurane but slightly more metabolized  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
inhalant analgesic but not anestheticweak CNS depressant used to decrease amount of other inhalants needed and increase speed of gas anesthetic uptake no respiratory depression and little cardiovascular effects can cause toxicity (rapid uptake of other inhalants), gas pockets in GI, and hypoxia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
non-depolarizing neuromuscular blockercompetitive antagonist of AChRs (Nm)➞ intense relaxation or paralysis of voluntary muscle (dose-dependent)prevents eye movement during ocular surgeryrapid reversal with AChEs (neostigmine, edrophenium)adverse effects: can trigger histamine release, metabolized to laudacarium and can trigger seizuresnow use lisatracarium (less adverse effects) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
bind receptor on cytoplasmic surface of voltage-sensitive Na+ channels and block pore ➞ Na+ cant enter cell ➞ inhibits APs in axonssmall fibers (ie pain) are blocked at lower concentrations ➞ motor fibers blocked last adverse effects: dose-dependent drowsiness ➞ excitations (seizures), ↓ excitability of myocardium ➞ AV block, arrhythmias, high concentrations = cardiac arrest, when with vasoconstrictor (ie. EP) ➞slow delayed healing and removal of drug ➞ prolongs action and doubles duration (toxicity) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
local anesthetic, arrhythmia (ventricular tachycardia/fibrillation)various administrationsoverdose = drowsiness or seizures ➞ muscle twitching and possibly cardiac arrest ➞ deathemergency situationssame mechanism as quinidine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
local anestheticslower onset but greater duration greater CVS toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
local anesthetic S-enantomer of Bupivacainedoesnt distribute to CNS and heart ➞ less CVS toxicities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
local anesthetic least irritating for eye |  | 
        |  |